1Georgieva M, Krasteva M, Angelova E, et al. Analysis of the K -ras/B - raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients [ J ]. Oncology Reports,2008,20(1 ) :3 - 11.
2Halatsch M E, Hirsch - Ernst K I, Weinel R J, et al. Differential activation of the c - Ki - ras - 2 proto - oncogene in human colorectal carcinoma [ J ]. Anticancer Research, 1998,18 ( 4A ) : 2323 - 2325.
3Der C J, Krontiris T G, Cooper G M. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses [ J ]. Proceedings of the National Academy of Sciences of the United States of America, 1982,79 ( 11 ) :3637 - 3640.
4Jones - Bolin S E, Johansson E, Palmisano W A, et al. Effect of promoter and intron 2 polymorphisms on murine lung K - ras gene expression [ J ]. Carcinogenesis, 1998,19 ( 8 ) : 1503 - 1508.
5Algarra I, Perez M, Serrano M J, et al. c - K - ras overexpression is characteristic for metastases derived from a methylcholanthrene - induced fibrosarcoma [ J ]. Invasion & Metastasis, 1998,18 (5 - 6) :261 - 270.
6Winder T, Mundlein A, Rhonaberg S, et al. Different types of K - ras mutations are conversely associated with overall survival in patients with colorectal cancer [ J ]. Oncology Reports, 2009,21 (5) :1283 - 1287.
7Barbacid M. K - ras genes [ J ]. Annual Review of Biochemistry, 1987,56:779 - 827.
8Walter M, Clark S G, Levinson A D. The oncogenic activation of human p21ras by a novel mechanism [J].Science, 1986,233 (4764) :649 - 652.
9Schmitz K J, Wohlschlaeger J, Alakus H, et al. Activation of extraeellular regulated kinases (ERKI/2) but not AKT predicts poor prognosis in colorcctal carcinoma and is associated with K - ras mutations[ J ]. Virchows Arch ,2007,450 ( 2 ) : 151 - 159.
10Calistri D,Rengucci C,Seymour I,et al. Mutation analysis of p53 ,Kras ,and BRAF genes in colorectal cancer progression[J].Journal of cellular physiology,21305,204(2) :484 - 488.
4Poehlmann A, Kuester D, Meyer F, et al. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique [J]. PatholResPract,2007,203(7):489 -497.
5Kristensen A T, Wiig J N, Larsen S G, et al. Molecular detection (K-ras) of exfoliated tumour cells in the pelvis is a prognostic factor after resection of rectal cancer [J]. BMC Cancer,2008,27(8) :213-221.
6Onozato W, Yamashita K, Yamashita K, et al. Genetic alterations of K ras may reflect prognosis in stage III colon cancer patients below 60 years of age [J]. J Surg Oncoi,2011, 103(1) :25-33.
7Estrada P, Rojas-Atencio A, Zabala W, et al. Frequency and clinicopathological associations of K ras mutations in Venezuelan patients with colorectal cancer [J]. Invest Clin, 2009,50(1) :55-63.
8Bengala C, Bettelli S, Bertolini F, et al. Epidermal growth factor receptor gene copy number, N ras mutation and pathological response to preoperative cetuximab, 5 FU and radiation therapy in locally advanced rectal cancer[J].Ann Oncol,2009,20(3) :469- 474.
9Swallow DM,Gendler S,Griffiths B,et al.The human tumor-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM[J].Nature,1987,328(2):82.
10Nakamori S,Ota DM,Cleary KR,et al.MUC1 mucin expression as a marker of progression and metastasis of human:colorectal carcinoma[J].Gastroenterology,1994,106(2):353-361.
